Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.

Detalles Bibliográficos
Publicado en:Future Oncology Vol. 22; no. 18; pp. 2221 - 2232
Autores principales: Zhang, Yanhui, Jin, Yuqin, Zhang, Ruidan, Zhao, Junfeng, Li, Baosheng
Formato: Journal Article
Publicado: Taylor & Francis Ltd Aug2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195864801&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195864801
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14796694
        3CMQ
      jtl: Future Oncology
      issn: 14796694
      maglogo: N
    pubinfo:
      dt: Aug2026
      vid: 22
      iid: 18
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        195864801
        10.1080/14796694.2026.2701482
        195864801
      ppf: 2221
      ppct: 11
      formats:
      tig:
        atl: Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study.
      aug:
        au:
          Zhang, Yanhui
          Jin, Yuqin
          Zhang, Ruidan
          Zhao, Junfeng
          Li, Baosheng
        affil: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N